a public good project by the
Synthesis
Company
of California

© 2026

Philippe Moullier | doi.page

0 works0 citations0 h-index

Philippe Moullier

Inserm(FR)AskBio (United States)(US)Nantes Université(FR)

Publications by Year

Research Areas

Virus-based gene therapy research, CRISPR and Genetic Engineering, RNA Interference and Gene Delivery, Retinal Development and Disorders, Viral Infectious Diseases and Gene Expression in Insects

Most-Cited Works

→ Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons(2009)493 cited
→ Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle(2008)297 cited
→ Factors Influencing Recombinant Adeno-Associated Virus Production(1998)238 cited
→ Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy(2017)230 cited
→ Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells(2000)206 cited
→ Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium(2006)200 cited

→ Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery(2003)196 cited

→ Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts(1993)178 cited

→ Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy(2014)168 cited

→ Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus(2002)147 cited